A landmark study using advanced gene-editing techniques has revealed something crucial: groundbreaking fertility research depends entirely on patients willing to donate their eggs and embryos. Yet most UK fertility clinics aren't giving patients that opportunity. Only about one in five clinics currently offer donation options, meaning whether you can contribute to science often depends on where you received treatment, not on your own wishes.

What's Driving This Gap in Research Participation?

The disconnect is striking. A recent Nature study used base editing, a highly precise genome-editing technique, to investigate how the NANOG gene shapes human embryo development in the earliest stages after fertilization. The research couldn't have happened without donated eggs from altruistic patients.

Yet the infrastructure to make donation routine remains sparse. Fertility clinics that want to offer research donation face administrative hurdles: they need additional consent processes, agreements with research centers, and logistics for transporting biological materials. These represent relatively modest additions to existing clinic workflows, but many clinics haven't made the investment.

The timing is particularly relevant now. Egg freezing has exploded in the UK, with around 5,580 egg-freezing cycles performed in 2024, compared with 2,567 in 2019. While many people eventually use their stored eggs, others won't. Some patients welcome the idea of donating unused eggs for ethically approved research if that option were presented sensitively.

"The research depended on the altruism of patients who choose to donate eggs for ethically approved research, within one of the world's most tightly regulated systems," explained Professor Kathy Niakan, the study's corresponding author. "She also said she hoped the study would raise awareness that fertility clinics can offer patients the opportunity to donate eggs, sperm and embryos for research, ensuring that anyone who wishes to contribute has the chance to do so."

Professor Kathy Niakan, Corresponding Author, Nature Study on Base Editing

How Could Clinics Make Donation More Accessible?

• Streamlined Consent: Broader consent arrangements could simplify the process, allowing patients to authorize research use of their eggs or embryos without extensive individualized paperwork for each donation.
• Centralized Research Banks: Establishing centralized research embryo banks would reduce the administrative burden on individual clinics while improving access for researchers who need donated materials.
• Cost-Sharing Models: Research grants can include funding to support transport, and cryogenic courier companies have indicated willingness to work with clinics and research institutions where batching research shipments reduces costs.

Importantly, clinics don't need to wait for legislative reform or new licensing requirements to expand donation options. They could discuss research donations alongside other end-of-storage options right now, enabling people to make informed choices that reflect their values.

Why Does This Matter for Fertility Treatment?

The recent base-editing study demonstrates exactly why patient donation matters. Researchers used the technique to investigate NANOG, a gene that plays a master-regulatory role in early human embryo development. By studying human embryos directly, rather than relying solely on animal models, scientists discovered that NANOG functions differently in humans than it does in mice, where it has been extensively studied.

In mice, NANOG signals to cells that will form the yolk sac, and without it the yolk sac fails to develop. In human embryos, by contrast, the yolk sac can still form without NANOG. This stark contrast in cell dynamics just days after fertilization underscores why studying human biology directly is essential.

These findings establish NANOG as a key regulator of early human embryonic development and advance our understanding of why some embryos may fail to develop or progress to the stage at which they can implant and result in a pregnancy. That knowledge could eventually improve fertility treatment outcomes.

"Although clinical applications may be years away, it is a reminder that scientific research should be guided by meaningful public engagement," noted Dr. Oliver Bower, lead author of the Nature study on base editing.

Dr. Oliver Bower, Founding Scientist, Preventive PBC

The Role of Patient Voices in Shaping Research Direction

Dr. Bower's own research journey illustrates how patient input can reshape scientific priorities. In September 2022, he participated in a citizens' jury involving people affected by genetic disease. The experience fundamentally changed his approach to his PhD research.

At the time, Bower was using traditional CRISPR/Cas9 gene-editing technology, which works like molecular scissors that cut DNA at precise locations. While effective for basic research, this approach can leave unintended changes at the cut site, raising concerns about therapeutic use. During the citizens' jury, patients and families emphasized that embryo editing might one day be justified for treating serious genetic disease, but only if it could be shown to be safe.

Inspired by that conversation, Bower pivoted his research to base editing, a more precise technique that works like "find and replace," changing a single DNA letter without breaking the DNA strand. Three years later, his team published their findings in Nature, demonstrating that base editing is highly efficient and capable of targeting DNA effectively while avoiding some complications of previous approaches.

The broader lesson: when researchers listen to patients and the public, they can develop technologies with greater potential for safe, ethical clinical application in the future.

What Happens Next?

The base-editing study doesn't mean this technology is ready for clinical use in treating genetic disease. Extensive preclinical research, continued studies of early human development, and ongoing public engagement will be essential before any clinical applications can be considered.

But the research does show that base editing can be used effectively to investigate human embryo development, providing encouraging evidence that it overcomes several limitations of traditional approaches. For that progress to continue, fertility clinics need to make it easier for patients to donate their unused eggs and embryos for ethically approved research. The science depends on it.